Medical Research News

RSS

Older men’s sexual priorities extend well beyond erectile function

A web-based survey of 6,000 Japanese men aged 50 or older found that sexual arousal was the function they most wanted to preserve, while erection became more highly valued as erectile function worsened. Erection showed the earliest age-related decline pattern, whereas ejaculation was the function most often reported as lost in older age.

6 Aug 2026

New review highlights FOXA2's role in glucose regulation pathways

A newly published review highlights the pivotal role of FOXA2, a key transcription factor, in coordinating pancreatic development, maintaining islet cell identity, and regulating glucose homeostasis.

6 Aug 2026

Healthy midlife habits linked to longer dementia-free years

Having normal blood pressure, no diabetes, and not smoking from age 48 to 68, are associated with nearly 13 additional years on average of dementia-free life, a new study shows.

6 Aug 2026

Scientists combine imaging and phototherapy in a single tool against glioblastoma

Glioblastoma is the most aggressive form of brain cancer.

6 Aug 2026

Cortisol may distort the body signals that guide risky choices in men

In a randomized study of 109 young adults, researchers measured cortisol responses, skin conductance signals, and risk-taking during the Iowa Gambling Task after an acute psychosocial stressor. Cortisol reactivity altered how anticipatory bodily signals related to risky choices in men, although the stress condition did not increase overall risk-taking.

5 Aug 2026

GLP-1 drug tirzepatide associated with lower risk of major cardiovascular events

Adding the GLP-1 receptor agonist drug tirzepatide (marketed as Mounjaro) to standard care for patients with type 2 diabetes and heart disease is associated with a lower risk of a major cardiovascular event, such as a heart attack or stroke, finds a study published by The BMJ today.

5 Aug 2026

Study reveals treatment gaps for atypical Alzheimer's disease patients

Many people with less common forms of Alzheimer's disease may not qualify for newer anti-amyloid treatments designed to slow the disease, according to a study published August 5, 2026, in Neurology®, the medical journal of the American Academy of Neurology.

5 Aug 2026

Long-acting HIV prevention tools could help close the gap before a vaccine arrives

A review of non-vaccine HIV interventions highlights the strong preventive effects of long-acting PrEP, sustained ART, U=U, vertical transmission programs, and voluntary medical male circumcision. Gene editing and multispecific antibodies may expand future options, but safety, cost, access, adherence, and implementation barriers remain.

5 Aug 2026

Neural stem cells split early into distinct neuron lineages

The cerebral cortex is densely packed with different nerve cells that enable us to perceive, think and act. Yet how these cell types arise while the brain develops is still not fully understood.

5 Aug 2026

Telemedicine expands access to pediatric primary care for endocrine or behavioral health issues

A multi-institutional study led by researchers at Children's Hospital of Philadelphia (CHOP) found that telemedicine is becoming increasingly common for problem-based primary care, particularly for children with endocrine or behavioral health issues where chronic needs are significant.

5 Aug 2026

Nerve-blocking therapy improves growth plate repair in injured bones

With the support of National Institutes of Health funding, Johns Hopkins Medicine investigators, led by pathologist Aaron W. James, M.D., Ph.D., previously discovered that sensory neurons in skeletal tissue are constantly sensing their environment and are quick to respond to injuries.

5 Aug 2026

Microbiome-based therapy may increase peanut allergy tolerance in adults

Some 33 million Americans have severe food allergies. Now, researchers at Boston Children's Hospital may have found a promising solution.

5 Aug 2026

Engineered spinal interneurons show promise for repairing spinal cord injuries

Spinal cord injuries affect an estimated 15 to 20 million people worldwide, often causing lasting impairments in movement, sensation, and independence.

5 Aug 2026

Experimental drug CS18 shows promise for overcoming cancer treatment resistance

Researchers at Baylor College of Medicine have developed a drug called CS18 that disrupts the ability of cancer cells to survive therapy. The findings, published in Science Advances, support exploring the possibility of using CS18 to treat human cancer in the future.

5 Aug 2026

Hypothyroidism linked to higher risk of obstructive sleep apnea

According to a study conducted in Brazil by researchers at the Federal University of São Paulo (UNIFESP) with participants from the São Paulo Epidemiological Sleep Study (EPISONO 2018), people with hypothyroidism experience a higher frequency and severity of obstructive sleep apnea (OSA).

5 Aug 2026